Skip to content
HealthMinute.TV

HealthMinute.TV

  • Home
  • Derm.City
  • Derm.Business
  • Chronicle Companies
  • Contact
May 23, 2024 chroniclepublishing atopic dermatitis

Antibiotics in first year of life linked to increased AD risk in infants

According to a recent study, early-life antibiotic use affects the gut microbiome which may lead to an increased risk of atopic dermatitis (AD).

May 16, 2024 chroniclepublishing research

Patients with HS at higher risk of respiratory disease

According to a recent study, hidradenitis suppurativa (HS) patients are at higher risk for respiratory diseases.

May 9, 2024 chroniclepublishing atopic dermatitis

Depression, suicidal ideation low in PsO patients on bimekizumab, according to new study

According to a recent study, suicidal ideation and behaviour and depression are low and within general psoriasis ranges in patients being treated with bimekizumab.

May 2, 2024 chroniclepublishing Skin Care

New study highlights delays in diagnosis for HS

According to a recent study, there are significant delays in diagnosis and low implementation rates for treatment for hidradenitis suppurativa (HS).

April 25, 2024 chroniclepublishing psoriasis

Topical melatonin, rosuvastatin may reduce severity of mild-to-moderate plaque PsO

According to a recent study, topical melatonin and topical rosuvastatin were both effective in reducing the severity of mild-to-moderate plaque psoriasis.

April 18, 2024 chroniclepublishing atopic dermatitis

New study shows dupilumab is efficacious, safe in treatment of AD in youth

According to a recent real-world study, dupilumab is safe and efficacious in treating moderate-to-severe atopic dermatitis (AD) in pediatric patients.

April 11, 2024 chroniclepublishing psoriasis

Guselkumab efficacious in PsO patients with history of cancer

According to a recent study, guselkumab is efficacious in patients with moderate-to-severe psoriasis and a history of cancer.

April 3, 2024 chroniclepublishing Skin Care

Lutikizumab effective in HS patients, new study shows

According to a recent study, lutikizumab 300 mg was shown to be more effective than placebo in hidradenitis suppurativa (HS) patients.

March 27, 2024March 28, 2024 chroniclepublishing psoriasis

Study shows apremilast effective for moderate-to-severe plaque PsO in pediatric patients

According to a recent study, apremilast is effective for the treatment moderate-to-severe plaque psoriasis short-term in pediatric patients.

March 21, 2024 chroniclepublishing psoriasis

Blood monocyte count in PsO patients may predict early response to secukinumab

According to a recent study, plaque psoriasis patients with lower blood monocyte counts at baseline achieved early response and better outcomes when treated with secukinumab.

Posts navigation

Older posts
Newer posts
Create a website or blog at WordPress.com
HealthMinute.TV
Create a website or blog at WordPress.com
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Subscribe Subscribed
    HealthMinute.TV
    Join 60 other subscribers

    Have a WordPress.com account? Log in now.

  • HealthMinute.TV
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar
Loading Comments...
Create your own website, free on WordPress.com.Create your own website.
Start free